BRASILIA (Reuters) – China will reduce its shipment of pharmaceutical ingredients for producing COVID-19 vaccines to Brazil’s Butantan biomedical institute next week to 3,000 liters from 4,000, Butantan said on Tuesday.
This means the shipment scheduled for May 26 will now make 5 million doses of the Coronavac shot, Butantan said, instead of the 7 million Sao Paulo state Governor Joao Doria had tweeted on Monday.
Butantan, which is backed by the state of Sao Paulo, is producing the Coronavac vaccine with China’s Sinovac.
(Reporting by Ricardo Brito; Writing by Jamie McGeever)
